US Patent 10711034 Integrated continuous manufacturing of therapeutic protein drug substances
Patent 10711034 was granted and assigned to Genzyme on July, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 21, 2017
0
Date of Patent
July 14, 2020
0
Patent Applicant
Patent Application Number
15493523
0
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10711034 Integrated continuous manufacturing of therapeutic protein drug substances
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.